BMA is a Swiss biotech founded by immunologists, developing and commercializing antibodies and ELISA kits for in-vitro research. It offers monoclonal and polyclonal antibodies made with serum-free media, supporting sustainability, reproducibility, and applications from cancer to infectious diseases.
Some insights
BMA’s core strength lies in its high-quality, Swiss-made antibodies and ELISA kits, produced with serum-free technology for sustainable, reproducible research. Backed by immunology expertise, it offers broad applications and customized solutions to meet diverse research needs.
